Hot Topics in Pharmacy: ASHP Advantage: Optimizing PARP Inhibitors Through Applying Evolving Technology and Clinical Evidence for Markers of Homologous Recombination Repair

Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.